Last updated on August 2019

An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)


Brief description of study

This is a prospective, multicenter, non-interventional study to test the safety and effectiveness of MabThera administered subcutaneously in participants with NHL or CLL. The length of study is expected to be 6 years.

Clinical Study Identifier: NCT03289182

Find a site near you

Start Over

Ulsan University Hosiptal

Ulsan, Korea, Republic of
  Connect »

Korea University Ansan Hospital

Gyeonggi-do, Korea, Republic of
  Connect »

Kangbuk Samsung Hospital

Seoul, Korea, Republic of
  Connect »

St. Vincent's Hospital

Gyeonggi-do, Korea, Republic of
  Connect »

Pusan National University Yangsan Hospital

Gyeongsangnam-do, Korea, Republic of
  Connect »